Updated Jul 16, 2026
Wood David S. is a corporate insider tracked by InsiderAlpha. No SEC Form 4 filings recorded in the last 90 days.
David S. Wood is the Chief Financial Officer of ESSA Pharma Inc., a biotechnology company focused on developing therapies for prostate cancer. He has extensive experience in finance and corporate management within the pharmaceutical and biotech sectors.
| Role | Chief Financial Officer |
|---|---|
| Notability | 60/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2025-10-09 | EPIX | ESSA Pharma Inc. | D — Derivative transaction | 33.3K | — |
David S. Wood is the Chief Financial Officer of ESSA Pharma Inc., a biotechnology company focused on developing therapies for prostate cancer. He has extensive experience in finance and corporate management within the pharmaceutical and biotech sectors.…
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Wood David S. profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.